A panel of experts advising the FDA is taking another look at the warnings tied to hormone therapy—specifically for menopause symptoms. This doesn’t mean the rules are changing yet, but it signals that new research or concerns might be prompting a fresh debate. Think of it as the scientific community hitting "pause" to double-check whether the current cautions still make sense.

Editor’s Note: Hormone therapy has been a rollercoaster for women—first hailed as a miracle, then linked to serious risks like cancer and heart disease. If the FDA revises its stance, it could shift how doctors prescribe these treatments and how women weigh the pros and cons. It’s a big deal because millions rely on these therapies, and clearer guidance could mean better (or at least less confusing) choices.